Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

The use of stimulant medication to treat neurocognitive deficits in patients with pediatric cancer, traumatic brain injury, and sickle cell disease: a review.

Nicholls E, Hildenbrand AK, Aggarwal R, McCarthy L, Daly B.

Postgrad Med. 2012 Sep;124(5):78-90. doi: 10.3810/pgm.2012.09.2596. Review.

PMID:
23095428
[PubMed - indexed for MEDLINE]
2.

Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature.

Berkelhammer LD, Williamson AL, Sanford SD, Dirksen CL, Sharp WG, Margulies AS, Prengler RA.

Child Neuropsychol. 2007 Mar;13(2):120-31. Review.

PMID:
17364569
[PubMed - indexed for MEDLINE]
3.
4.

Pharmacological stimulant treatment of neurocognitive and functional deficits after traumatic and non-traumatic brain injury.

Napolitano E, Elovic EP, Qureshi AI.

Med Sci Monit. 2005 Jun;11(6):RA212-220. Epub 2005 May 25. Review.

PMID:
15917733
[PubMed - indexed for MEDLINE]
5.

Scholarly literature review: management of neurocognitive late effects with stimulant medication.

Daly BP, Brown RT.

J Pediatr Psychol. 2007 Oct;32(9):1111-26. Epub 2007 Apr 18. Review.

PMID:
17442692
[PubMed - indexed for MEDLINE]
Free Article
6.

Psychopharmacological treatment for cognitive impairment in survivors of traumatic brain injury: a critical review.

Writer BW, Schillerstrom JE.

J Neuropsychiatry Clin Neurosci. 2009 Fall;21(4):362-70. doi: 10.1176/appi.neuropsych.21.4.362. Review.

PMID:
19996244
[PubMed - indexed for MEDLINE]
7.

Pharmacological management of the psychiatric aspects of traumatic brain injury.

Lee HB, Lyketsos CG, Rao V.

Int Rev Psychiatry. 2003 Nov;15(4):359-70. Review.

PMID:
15276957
[PubMed - indexed for MEDLINE]
8.

Neurocognitive aspects of pediatric sickle cell disease.

Brown RT, Armstrong FD, Eckman JR.

J Learn Disabil. 1993 Jan;26(1):33-45. Review.

PMID:
8418188
[PubMed - indexed for MEDLINE]
9.

[Pharmacotherapy of the cognitive sequelae secondary to traumatic brain injury].

Riós-Romenets S, Castaño-Monsalve B, Bernabeu-Guitart M.

Rev Neurol. 2007 Nov 1-15;45(9):563-70. Review. Spanish.

PMID:
17979087
[PubMed - indexed for MEDLINE]
Free Article
10.

Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations.

Hammerness PG, Perrin JM, Shelley-Abrahamson R, Wilens TE.

J Am Acad Child Adolesc Psychiatry. 2011 Oct;50(10):978-90. doi: 10.1016/j.jaac.2011.07.018. Epub 2011 Sep 3. Review.

PMID:
21961773
[PubMed - indexed for MEDLINE]
11.

Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies.

Cohen-Zion M, Ancoli-Israel S.

Sleep Med Rev. 2004 Oct;8(5):379-402. Review.

PMID:
15336238
[PubMed - indexed for MEDLINE]
12.

Attention-deficit/hyperactivity disorder.

Shaywitz BA, Fletcher JM, Shaywitz SE.

Adv Pediatr. 1997;44:331-67. Review.

PMID:
9265975
[PubMed - indexed for MEDLINE]
13.

What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD).

Advokat C.

Neurosci Biobehav Rev. 2010 Jul;34(8):1256-66. doi: 10.1016/j.neubiorev.2010.03.006. Epub 2010 Apr 8. Review.

PMID:
20381522
[PubMed - indexed for MEDLINE]
14.

Stimulant medication for the child with attention-deficit/hyperactivity disorder.

Bennett FC, Brown RT, Craver J, Anderson D.

Pediatr Clin North Am. 1999 Oct;46(5):929-44, vii. Review.

PMID:
10570697
[PubMed - indexed for MEDLINE]
15.

Stimulant medications.

Greenhill LL, Halperin JM, Abikoff H.

J Am Acad Child Adolesc Psychiatry. 1999 May;38(5):503-12. Review.

PMID:
10230181
[PubMed - indexed for MEDLINE]
16.

Cognitive and behavioral function in children with sickle cell disease: a review and discussion of methodological issues.

White DA, DeBaun M.

J Pediatr Hematol Oncol. 1998 Sep-Oct;20(5):458-62. Review.

PMID:
9787319
[PubMed - indexed for MEDLINE]
17.

A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance.

Barkley RA, Cox D.

J Safety Res. 2007;38(1):113-28. Epub 2007 Feb 15. Review.

PMID:
17303170
[PubMed - indexed for MEDLINE]
18.

Pharmacotherapy of attention deficit hyperactivity disorder.

Spencer T, Biederman J, Wilens T.

Child Adolesc Psychiatr Clin N Am. 2000 Jan;9(1):77-97. Review.

PMID:
10674191
[PubMed - indexed for MEDLINE]
19.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
[PubMed - indexed for MEDLINE]
20.

Sickle cell disease as a neurodevelopmental disorder.

Schatz J, McClellan CB.

Ment Retard Dev Disabil Res Rev. 2006;12(3):200-7. Review.

PMID:
17061284
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk